Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy
Comparison of High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy in Treatment of Lateral Epicondylitis: A Randomized Controlled Study
1 other identifier
interventional
40
1 country
1
Brief Summary
Objectives: This study aims to evaluate and compare the short-term efficacy of high-intensity laser therapy (HILT) and extra corporeal shock wave therapy(ESWT) on pain, sensitivity, handgrip strength, and functions in the treatment of lateral epicondylitis (LE). Material and methods: Forty five participants (age range, 18 to 65 years) with unilateral elbow pain were randomized into two groups. HILT group (n = 22) and the ESWT group (n = 23). The HILT and ESWT were administered three times a week for three weeks, and each treatment was combined with exercises. All patients in both groups were evaluated with ultrasonography for common extensor tendon(CET) thickness. A visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QDASH), and hand grip strength test were used to evaluate the patients before, one, and six weeks after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedFirst Submitted
Initial submission to the registry
February 21, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedMarch 8, 2024
March 1, 2024
1 month
February 21, 2024
March 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analog scale
score 0-10, 0 minimum value, mean is no pain, score 10 is maximum value, pain is very severe
Baseline, 1 week and 6 weeks
Secondary Outcomes (3)
Quick Disability Arm, Shoulder and Hand questionary,
Baseline, 1 week and 6 weeks
hand grip strength
Baseline, 1 week and 6 weeks
musculoskeletal ultrasonography
Baseline, 1 week and 6 weeks
Study Arms (2)
high intensive laser
EXPERIMENTALhigh-intensity laser was applied 3 times in a week, for three weeks, total of 9 sessions
extracorporeal shock wave therapy
EXPERIMENTALextracorporeal shock wave therapy was applied once a week, for three weeks total of 3 sessions
Interventions
high-intensity laser ,three times in a week, for three weeks, 9 session
extracorporeal shock wave therapy, once a week, for three weeks ,3 times,
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Lateral epicondylitis
- Age \>18
You may not qualify if:
- Operation history about elbow
- Received physical therapy, or had a steroid injection to the elbow in the three months
- Cervical radiculopathy,
- Elbow deformities,
- Fibromyalgia syndrome,
- Carpal tunnel syndrome,
- Neurological impairments in the upper extremity,
- Chronic inflammatory conditions,
- Hemophilia,
- Pregnant,
- History of malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emine Esra Bilir
Ankara, Çankaya, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2024
First Posted
March 8, 2024
Study Start
September 1, 2022
Primary Completion
October 1, 2022
Study Completion
May 30, 2023
Last Updated
March 8, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share